Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Email Alerting on Reducing Hospital Employees' Unauthorized Access to Protected Health Information: A Nonrandomized Controlled Trial

NCT05251844 is registered in ClinicalTrials.gov with Protenus, Inc. as lead sponsor.

NCT NCT05251844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05251844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Email Alerting on Reducing Hospital Employees' Unauthorized Access to Protected Health Information: A Nonrandomized Controlled Trial
Lead sponsor
Protenus, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2018
Completion date
September 30, 2021
Enrollment
444 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unauthorized data access